Bioequivalence and Bioavailability Forum 12:54 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

libaiyi
Junior

China,
2018-07-27 11:45

Posting: # 19109
Views: 181
 

 Overall and Subpopulation p value consideration [General Sta­tis­tics]

Hi,all

If whether the statistical analysis result is significant in the overall population or a subpopulation (multicenter study design) could be considered as a significant result for the clinical trail, should the alpha the same as common BE study? Is there any difference in the hypothesis test and statistical analysis process?

Thanks in advance!:-D:-D:-D
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,606 posts in 3,959 threads, 1,212 registered users;
online 18 (0 registered, 18 guests [including 17 identified bots]).

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed